Log in to save to my catalogue

Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the...

Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A753061654

Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score

About this item

Full title

Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Urologia internationalis, 2023-05, Vol.107 (5), p.489-495

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Purpose: There is increasing evidence that a persistent systemic inflammatory response predicts lower survival in patients with malignant disease. The modified Glasgow Prognostic Score (mGPS) is defined by a combination of elevated C-reactive protein (CRP) (>10 mg/L) and hypoalbuminemia (<35 g/L). It is considered as an independent prognostic marke...

Alternative Titles

Full title

Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracacademiconefile_A753061654

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracacademiconefile_A753061654

Other Identifiers

ISSN

0042-1138

E-ISSN

1423-0399

DOI

10.1159/000519358

How to access this item